Plus Products Launches New PLUS SLEEP Brand, Extends Portfolio of Best-Selling Cannabis Gummies


Ryan Allway

September 3rd, 2020

News, Top News


Source: Plus Products Inc.

photo-release
PLUS SLEEP Product Lineup
PLUS SLEEP Photo
PLUS’s new SLEEP gummies are scientifically formulated with a precise blend of cannabinoids and melatonin intended to help consumers fall asleep quickly and enjoy a full, restful night’s sleep.

SAN MATEO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis and hemp branded products company in the U.S., today announced the launch of its new PLUS SLEEP brand into the California adult-use market.

Highlights

  • 4 key ingredients to promote a well-rounded night of sleep: THC, CBN, CBD, and just a touch of melatonin.
  • All-natural colors and flavors, with only 0.7g of sugar and 5 calories per gummy.
  • 2 formulations to offer multiple potential solutions to a wide range of consumers: Sleep Cloudberry, with 5mg of THC, 1mg of CBN, and 1mg of CBD, along with CBNRelief Lychee, with 1mg of THC, 2mg of CBN, and 3mg of CBD.

PLUS’s new SLEEP gummies are scientifically formulated with a precise blend of cannabinoids and melatonin intended to help consumers fall asleep quickly and enjoy a full, restful night’s sleep.

Recent research on the interaction between cannabis, the endocannabinoid system, and the body’s natural circadian rhythm¹ drove PLUS’s formulations of the two new SLEEP products. “Each cannabinoid was selected for how it promotes better sleep, but together they have the potential to be greater than the sum of their parts. This is often referred to as the entourage effect.2 We also included a physiologic dose of melatonin to support our bodies’ circadian rhythm, so these gummies actually work in concert with our natural systems,” stated Dr. Ari Mackler, Chief Scientific Officer.

“We’re excited to help the 71% of cannabis sleep aid users who are not satisfied with their current remedies3,” stated Jake Heimark, CEO and Co-Founder. “Almost 50 million people in the US suffer from insomnia.It’s no surprise  we hear all the time that one of the top things people look for when they walk into a licensed retailer is something to help them sleep.”

(1) [1] Hodges EL, Ashpole NM. Aging circadian rhythms and cannabinoids. Neurobiol Aging. 2019;79:110-118.  [2]. Hanlon EC. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). Psychoneuroendocrinology. 2020;111:104471.  [3] Antony JM, McDonald AC, Noorbakhsh F, Guthrie N, Evans M. Changing the Tone of Clinical Study Design in the Cannabis Industry. Transl Neurosci. 2020;11:4-9.
(2) Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364.
(3) BrightField Consumer Survey (July 2020)
(4) Ford ES, Cunningham TJ, Giles WH, Croft JB. Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012. Sleep Med. 2015;16(3):372-378.
(5) Title: PLUS was the best-selling gummies brand in California during the full year 2019 according to BDS analytics.

Upcoming Events To Learn More

  • Sleepy Time SeriesGet tucked in every Tuesday night with PLUS! Throughout the month of September, PLUS is hosting a series of free Instagram Live sessions to help you unwind, ease your mind, and drift off to sleep! From breath work to yoga, wind down with PLUS from the comfort of your own bed! For more information visit https://plusproductsthc.com/sleep.
  • Bedtime Chat with the ExpertsPLUS’s Chief Scientific Officer, Dr. Ari Mackler and Sleep Expert, Dr. Michael Breus (@thesleepdoctor) have teamed up for a live, virtual conversation on the science of sleep. On Monday, Sept 16th, they will decode how cannabis plays a role in sleep by providing a deep dive into the latest research on the interaction of cannabinoids on our bodies and sleep systems. To register for the free webinar, visit https://plusproductsthc.com/sleepwebinar.

Availability

California THC: PLUS cannabis-infused edibles are currently available in over 360 licensed retailers across the state of California. PLUS SLEEP edibles are expected to roll out to licensed retailers across the state in the coming weeks – visit plusproductsthc.com/sleep to find participating locations.

Nevada THC: PLUS cannabis-infused gummies are currently available in licensed retailers throughout Las Vegas.

National Hemp CBD: PLUS 100% hemp CBD-infused gummies are available for purchase in 43 states across the country at plusproducts.com.

About PLUS

PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e9883ade-b510-4264-9968-34666db593b1

For further information contact:

Jake Heimark
CEO & Co-founder
[email protected]

Investors:

Blake Brennan
Investor Relations
[email protected]

Tel +1 213.282.6987

Media:

Megan Sekkas
Public Relations
[email protected]
Tel +310.279.6811

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This press release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (each, a “forward-looking statement”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur and include, but are not limited to, statements relating to: (i) the extent to which, if at all, PLUS SLEEP gummies and the active ingredients within them will promote a better night’s sleep; (ii) the extent to which, if at all, PLUS SLEEP cannabis-infused gummies will be rolled-out across California in coming weeks.

These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the success of the Company’s investments, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of the Company’s products, customer experience and retention, the continued development of adult-use sales channels, managements estimation of consumer demand in in jurisdictions where the Company exports, expectations of future results and expenses, the availability of additional capital to complete capital projects and facilities improvements, the ability to expand and maintain distribution capabilities, the impact of competition, the ability of the Company to implement initiatives and the possibility for changes in laws, rules, and regulations in the industry. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading